Among 65 evaluable patients with sufficient tumour samples for NGS, the most frequent concomitant gene mutations were p53 (49%), MDM2 (25%), and POT1 (in 8 pts with sarcomatoid histologies). This evidence concerns the gene TP53 and neoplasm.